R Egbring
Overview
Explore the profile of R Egbring including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilmer M, Rudin K, Kolde H, Poetzsch B, Lenz W, Moessmer G, et al.
Thromb Res
. 2001 Apr;
102(1):81-91.
PMID: 11323018
There is an increasing interest in the role of coagulation factor XIII (FXIII) in cardio- and cerebrovascular diseases. It has recently been reported that a common G-->T point mutation in...
2.
Wirth T, Schneider B, Misselwitz F, Lomb M, Tuylu H, Egbring R, et al.
Arthroscopy
. 2001 Apr;
17(4):393-9.
PMID: 11288011
Purpose: Deep venous thrombosis (DVT) is a common, important complication of major orthopaedic surgery, particularly knee arthroplasty. Knee arthroscopy is increasingly performed on an outpatient basis. Few reports have elucidated...
3.
Holst F, Hemmer C, Foth C, Seitz R, Egbring R, Dietrich M
Am J Trop Med Hyg
. 1999 Feb;
60(1):99-104.
PMID: 9988331
Plasmodium falciparum malaria is associated with procoagulant activity but not with thromboembolism. We measured coagulation factor XIII, i.e., fibrin-stabilizing factor, in 45 patients with falciparum malaria over time. Of these,...
4.
Sugo T, Nakamikawa C, Takebe M, Kohno I, Egbring R, Matsuda M
Blood
. 1998 May;
91(9):3282-8.
PMID: 9558384
The truncated Aalpha-chain of fibrinogen Marburg is partly linked with albumin by a disulfide bond. Based on the recovery of the first six amino acid residues assigned to the subunit...
5.
Seitz R, Heidtmann H, Wolf M, Immel A, Egbring R
Ann Oncol
. 1997 Aug;
8(8):781-4.
PMID: 9332686
Background: There is evidence that activation of coagulation by influencing tumour biology may have impact on clinical course of lung cancer. Patients And Methods: We measured the activation markers thrombin-antithrombin...
6.
Hemmer C, Hort G, Chiwakata C, Seitz R, Egbring R, Gaus W, et al.
Am J Trop Med Hyg
. 1997 Apr;
56(4):397-403.
PMID: 9158047
Pentoxifylline (POF) may suppress overproduction of tumor necrosis factor alpha (TNF alpha), which is thought to contribute to complications of human falciparum malaria. However, POF is believed to improve impaired...
7.
Heiden M, Seitz R, Egbring R
Semin Thromb Hemost
. 1996 Jan;
22(6):497-501.
PMID: 9122714
Extravascular fibrin formation and dissolution is a pivotal event in numerous inflammatory and malignant diseases. In inflammatory cells such as monocytes/macrophages, neutrophil granulocytes appear to interact intimately with hemostasis and...
8.
Egbring R, Kroniger A, Seitz R
Semin Thromb Hemost
. 1996 Jan;
22(5):419-25.
PMID: 8989826
Congenital factor XIII deficiency is a rare disease, but has provided valuable information on the physiological role of factor XIII and the benefit of factor XIII replacement therapy. It could...
9.
Mikkola H, Yee V, Syrjala M, Seitz R, Egbring R, Petrini P, et al.
Blood
. 1996 Jan;
87(1):141-51.
PMID: 8547636
The characterization of naturally occurring mutations is one way to approach functionally significant domains of polypeptides. About 10 mutations have been reported in factor XIII (FXIII) A-subunit deficiency, but very...
10.
Brackmann H, Egbring R, Ferster A, Fondu P, Girardel J, Kreuz W, et al.
Thromb Haemost
. 1995 Aug;
74(2):622-5.
PMID: 8584996
The pharmacokinetics and tolerability of factor XIII (FXIII) from plasma were compared with those of FXIII from placenta in a randomised, double-blind, crossover study involving 13 patients with congenital FXIII...